Christopher Bowden, Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 21,886 shares at $60.04 ($1.3M) on 2021-06-07, disclosed to the SEC on 2021-06-09.
Open-market sale of $1.3M AGIO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.04 | 4,268 | $256K | 19.5% |
| 2 | $60.04 | 4,268 | $256K | 19.5% |
| 3 | $60.07 | 6,675 | $401K | 30.5% |
| 4 | $60.07 | 6,675 | $401K | 30.5% |
| Total | $60.06 avg | 21,886 | $1.3M | 100% |
| Filing → |
| AGIO | SELL | 2021-06-11 | $3.4M | — | Filing → |
| AGIO | SELL | 2021-04-21 | $1.9M | — | Filing → |
| AGIO | SELL | 2020-05-21 | $358K | — | Filing → |